MeSH Browser

MeSH Heading: Rabeprazole
Tree Number(s): D02.886.640.074.750; D03.383.725.024.750; D03.633.100.103.034.750
Unique ID: D064750
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D064750
Scope Note: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
Entry Term(s): 1H-Benzimidazole, 2-(((4-(3-methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-, Sodium Salt; 2-((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methylsulfinyl)-1H-benzimidazole; Aciphex; Dexrabeprazole; E 3810; E3810; LY-307640; LY307640; Pariet; Rabeprazole Sodium
Pharm Action: Anti-Ulcer Agents
Proton Pump Inhibitors
Registry Numbers: 32828355LL; 0; 3L36P16U4R
Related Numbers: 117976-90-6; 3L36P16U4R
Public MeSH Note: 2014; RABEPRAZOLE was indexed under 2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES 1990-2013
History Note: 2014
Date Established: 2014/01/01
Date of Entry: 2013/07/08
Revision Date: 2016/07/01

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Rabeprazole MeSH Descriptor Data 2024